Latest FDA Stories
AIX-EN-PROVENCE, France, Dec.
Finalized rules will usher in new era for the $19 Billion Automated Retailing Market CORONA, Calif., Dec. 1, 2014 /PRNewswire/ -- AVT, Inc.
Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Treatment SAN FRANCISCO, Dec.
Integrated System Streamlines Diabetes Management for Patients CHESTERBROOK, Pa., Dec.
IGI Now Has Nineteen Applications Pending at the FDA BUENA, N.J., Dec. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
Accurate Norovirus Detection in as Little as One Hour SUNNYVALE, Calif., Dec. 1, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S.
An independent compliance audit found that SureClinical eTMF Cloud meets or exceeds European Commission and FDA regulatory requirements. Rancho Cordova, CA (PRWEB)
On November 24, the US FDA notified consumers not to purchase or use Super Extreme Accelerator because it contains undeclared drug ingredient.
On November 24, the US FDA notified consumers not to purchase or use Bee Slim due to undeclared drug ingredient.
- A gift; a largess; a gratuity; a present; a dole.